Pulmonary vasodilation in acute pulmonary embolism – a systematic review
Acute pulmonary embolism is the third most common cause of cardiovascular death. Pulmonary embolism increases right ventricular afterload, which causes right ventricular failure, circulatory collapse and death. Most treatments focus on removal of the mechanical obstruction caused by the embolism, bu...
Main Authors: | Mads Dam Lyhne, Jeffrey Allen Kline, Jens Erik Nielsen-Kudsk, Asger Andersen |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-03-01
|
Series: | Pulmonary Circulation |
Online Access: | https://doi.org/10.1177/2045894019899775 |
Similar Items
-
Levosimendan, milrinone, and dobutamine in experimental acute pulmonary embolism
by: Mads D. Lyhne, et al.
Published: (2021-06-01) -
Pulmonary vasodilation by sildenafil in acute intermediate-high risk pulmonary embolism: a randomized explorative trial
by: Asger Andersen, et al.
Published: (2021-02-01) -
A porcine model of acute pulmonary embolism
by: Jacob Schultz, et al.
Published: (2017-11-01) -
Levosimendan in pulmonary hypertension and right heart failure
by: Mona Sahlholdt Hansen, et al.
Published: (2018-07-01) -
Endogenously released adenosine causes pulmonary vasodilation during the acute phase of pulmonary embolization in dogs
by: Hiroko Takahama, et al.
Published: (2019-09-01)